Skip to content

Drug interactions

Apalutamide + Lomitapide

Severity: Moderate

Apalutamide and Lomitapide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Apalutamide may reduce lomitapide exposure because lomitapide is extensively metabolized by CYP3A4. This may lessen LDL cholesterol lowering.

What this interaction means in plain words

Apalutamide and Lomitapide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Apalutamide belongs to Endocrine; Lomitapide belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

CYP3A4 induction by apalutamide increases lomitapide clearance.

What to do

Monitor LDL cholesterol and consider titrating lomitapide according to response and liver tests. Consider alternative lipid-lowering therapy if efficacy is lost.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Apalutamide and Lomitapide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Apalutamide with Lomitapide?

MediHelp rates the interaction as moderate. Apalutamide and Lomitapide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Apalutamide may reduce lomitapide exposure because lomitapide is extensively metabolized by CYP3A4. This may lessen LDL cholesterol lowering.

How serious is the interaction between Apalutamide and Lomitapide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor LDL cholesterol and consider titrating lomitapide according to response and liver tests. Consider alternative lipid-lowering therapy if efficacy is lost.

What other medicines interact with Apalutamide?

MediHelp also lists interactions of Apalutamide with, for example, Cabotegravir, Cobicistat, Doravirine. The full list is on the Apalutamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in